Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Cathepsin K–deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression
Sutada Lotinun, … , Francesca Gori, Roland Baron
Sutada Lotinun, … , Francesca Gori, Roland Baron
Published May 21, 2019
Citation Information: J Clin Invest. 2019;129(8):3058-3071. https://doi.org/10.1172/JCI122936.
View: Text | PDF
Research Article Bone Biology Endocrinology

Cathepsin K–deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression

  • Text
  • PDF
Abstract

Lactation induces bone loss to provide sufficient calcium in the milk, a process that involves osteoclastic bone resorption but also osteocytes and perilacunar resorption. The exact mechanisms by which osteocytes contribute to bone loss remain elusive. Osteocytes express genes required in osteoclasts for bone resorption, including cathepsin K (Ctsk), and lactation elevates their expression. We show that Ctsk deletion in osteocytes prevented the increase in osteocyte lacunar area seen during lactation, as well as the effects of lactation to increase osteoclast numbers and decrease trabecular bone volume, cortical thickness, and mechanical properties. In addition, we show that Ctsk deletion in osteocytes increased bone parathyroid hormone–related peptide (PTHrP) and prevented the decrease in serum parathyroid hormone (PTH) induced by lactation, but amplified the increase in serum 1,25-dyhydroxyvitamin D [1,25(OH)2D]. The net result of these changes is to maintain serum and milk calcium levels in the normal range, ensuring normal offspring skeletal development. Our studies confirm the fundamental role of osteocytic perilacunar remodeling in physiological states of lactation and provide genetic evidence that osteocyte-derived Ctsk contributes not only to osteocyte perilacunar remodeling, but also to the regulation of PTH, PTHrP, 1,25(OH)2D, osteoclastogenesis, and bone loss in response to the high calcium demand associated with lactation.

Authors

Sutada Lotinun, Yoshihito Ishihara, Kenichi Nagano, Riku Kiviranta, Vincent T. Carpentier, Lynn Neff, Virginia Parkman, Noriko Ide, Dorothy Hu, Pamela Dann, Daniel Brooks, Mary L. Bouxsein, John Wysolmerski, Francesca Gori, Roland Baron

×

Figure 10

Schematic representation of the relationship between osteocytic osteolysis, bone remodeling, and calcium metabolism during lactation in mice in the presence or absence of Ctsk in osteocytes.

Options: View larger image (or click on image) Download as PowerPoint
Schematic representation of the relationship between osteocytic osteolys...
(A) In the presence of Ctsk in osteocytes (control lactating mice), the changes induced by the lactating mammary gland, including increased secretion of PTHrP, switch the osteocytes to the resorbing mode, increasing TRAP activity and Ctsk expression and leading to increased perilacunar resorption (PLR) and lacunar enlargement. These changes in the osteocyte microenvironment lead to an increase in PTHrP and the Rankl/Opg ratio, thereby increasing osteoclastogenesis, bone resorption, and serum calcium. This increase in serum calcium is also secondary to higher PTHrP and 1,25(OH)2D acting on the kidney and the gut, resulting in both calcium supply to the milk and repression of endogenous PTH secretion. (B) In the absence of Ctsk in osteocytes (Ctskocy lactating mice), although the changes induced in the mammary gland by lactation increase TRAP activity and Pthrp in osteocytes, deletion of Ctsk prevents PLR, enlargement of the lacuna, and an increase in the Rankl/Opg ratio and osteoclastogenesis. The lack of osteocytic osteolysis and osteoclastogenesis limits the supply of calcium to serum; this is sensed by the parathyroid gland, which continues to secrete PTH at prelactation levels and, together with PTHrP, enhances 1,25(OH)2D levels and thus calcium absorption from the gut, compensating for the limited supply of calcium coming from bone and ensuring appropriate calcium levels in the blood and milk.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts